Status:
COMPLETED
Cardiac Function Non-Invasive Monitoring System Evaluation Trial
Lead Sponsor:
Sensydia Corporation
Collaborating Sponsors:
University of Pittsburgh Medical Center
Conditions:
Cardiac Disease
Eligibility:
All Genders
18+ years
Brief Summary
Non-significant risk device study to conduct evaluation of the performance of new device for monitoring of cardiac function (based on previous iterations 510(k) 173156)
Detailed Description
Non-significant risk device study to conduct evaluation of the performance of new device for monitoring of cardiac function (based on previous iterations 510(k) 173156)
Eligibility Criteria
Inclusion
- Adults of age 18 or older
Exclusion
- Subjects with wounds or surgical incisions at the site of sensor placement
Key Trial Info
Start Date :
November 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2023
Estimated Enrollment :
275 Patients enrolled
Trial Details
Trial ID
NCT04131725
Start Date
November 9 2020
End Date
April 30 2023
Last Update
November 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15261